- Rhythm Pharmaceuticals (NASDAQ:RYTM) shares dipped 3.3% premarket on Thursday after the company priced its upsized offering of 2,058,824 shares of its common stock at $85.00 per share.
- In addition, the firm also granted the underwriters a 30-day option to purchase up
Rhythm Pharmaceuticals prices $175M stock offering

Related
Omega Healthcare tenant Genesis gets stalking horse bid from...
9 minutes ago
0
Cognition soars 35% after positive FDA meeting on Alzheimer'...
13 minutes ago
0
S&P 500's new record high pushes the index into overbought t...
16 minutes ago
0
Methode Electronics projects $70M–$80M EBITDA in fiscal 2026...
20 minutes ago
0
Fed's Daly says it's time to think about 'adjusting' rates, ...
22 minutes ago
0
Jamie Dimon gets real with Europe about shrinking to just 65...
25 minutes ago
0
Huntington Ingalls upgraded at TD Cowen on contract momentum...
27 minutes ago
0
Elon Musk’s Tesla finally sets a shareholder meeting amid do...
35 minutes ago
0
Private equity roll-ups are undermining the free enterprise ...
48 minutes ago
0
Mali military helicopter airlifts gold from Barrick's Loulo-...
59 minutes ago
0
Delta Air Lines' upbeat outlook fuels travel rally
2 hours ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved